LOADING
Comparing Visa Inc (V) and Thermo Fisher Scientific (TMO) across the Financials and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | V | TMO |
|---|---|---|
| Price | $381.46 | $624.83 |
| Change Today | +2.81% | -0.71% |
| Market Cap | $692.7B | $232.7B |
| P/E Ratio | 31.6 | 33.9 |
| Forward P/E | 24.7 | 25.1 |
| PEG Ratio | 1.68 | 2.05 |
| EPS | $11.76 | $18.56 |
| Revenue Growth (YoY) | 14.4% | 10.5% |
| Profit Margin | 50.8% | 15.0% |
| Return on Equity | 61.2% | 13.5% |
| Dividend Yield | 0.73% | 0.29% |
| Beta | 0.76 | 0.85 |
| 52-Week High | $373.28 | $642.71 |
| 52-Week Low | $292.74 | $434.83 |
| Volume | 194K | 68K |
Visa Inc is the larger company by market capitalization. Visa Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Visa Inc offers a higher dividend yield for income investors. Visa Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.